Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Baharudin Abdullah, Amir Hamzah Abdul Latiff, Anura Michelle Manuel, Faizah Mohamed Jamli, Harvinder Singh Dalip Singh, Intan Hakimah Ismail, Jeevanan Jahendran, Jeyasakthy Saniasiaya, Kent Chee Keen Woo, Phaik Choo Khoo, Kuljit Singh, Nurashikin Mohammad, Sakinah Mohamad, Salina Husain & Ralph Mösges. (2022) Pharmacological Management of Allergic Rhinitis: A Consensus Statement from the Malaysian Society of Allergy and Immunology. Journal of Asthma and Allergy 15, pages 983-1003.
Read now
Read now
Christian Vogelberg, Bernd Brüggenjürgen, Hartmut Richter & Marek Jutel. (2020) Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma. Patient Preference and Adherence 14, pages 817-827.
Read now
Read now
Zhiying Shen, Guolin Tan, Zhuqing Zhong, Siqing Ding & Fang Wang. (2019) Interactive Network Platform Improves Compliance and Efficacy of Subcutaneous Immunotherapy for Patients with Allergic Rhinitis. Patient Preference and Adherence 13, pages 2101-2110.
Read now
Read now
Bernd Brüggenjürgen & Thomas Reinhold. (2018) Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria, Spain, and Switzerland. Journal of Medical Economics 21:4, pages 374-381.
Read now
Read now
Marie-Luise Lemberg, Till Berk, Kija Shah-Hosseini, Elena-Manja Kasche & Ralph Mösges. (2017) Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center. Patient Preference and Adherence 11, pages 63-70.
Read now
Read now
Articles from other publishers (38)
Danilo Di Bona, Palma Carlucci, Federico Spataro, Giovanni Paoletti, Enrico Heffler, Jaakko Pulkanen, Luigi Macchia, Stefano Del Giacco, Ioana Agache, Marek Jutel, Holger J. Schünemann & Giorgio Walter Canonica. (2023) Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy. Clinical & Experimental Allergy 53:6, pages 610-625.
Crossref
Crossref
Jun Mendoza, Geoffrey Carlson, Priya Nath & James Quinn. (2023) A look at adherence with subcutaneous immunotherapy without out-of-pocket patient costs. Annals of Allergy, Asthma & Immunology.
Crossref
Crossref
Caroline Beutner, Jochen Schmitt, Margitta Worm, Martin Wagenmann, Christian Albus & Timo Buhl. (2023) Lack of Harmonized Adherence Criteria in Allergen Immunotherapy Prevents Comparison of Dosing and Application Strategies: A Scoping Review. The Journal of Allergy and Clinical Immunology: In Practice 11:2, pages 439-448.e6.
Crossref
Crossref
Désirée Larenas-Linnemann. (2022) Long-term adherence strategies for allergen immunotherapy. Allergy and Asthma Proceedings 43:4, pages 299-304.
Crossref
Crossref
Teruyuki Sato, Nobuo Ohta, Atsushi Yuta, Yukiko Ogawa, Takahiro Suzuki, Fumi Shoji, Naoya Noguchi, Naohiro Suzuki, Chikashi Kusakari, Kunitsugu Tabata, Eikan Kaku, Naohiro Okitsu, Jun Hasegawa, Yoshihiro Shibahara, Seiichiro Nakabayashi, Naoki Inamura, Yoshiyuki Ohi, Yoshitaka Takanashi, Jun Suzuki, Mitsuru Sugawara, Kazuhiro Nomura, Yukio Katori & Yoshitaka Okamoto. (2022) Comparative Survey of Children and Adults with Japanese Cedar Pollinosis Using a Self-written Questionnaire on Sublingual Immunotherapy in Clinical Practiceスギ花粉症に対する舌下免疫療法の小児と成人における比較調査. Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo) 125:5, pages 876-883.
Crossref
Crossref
Anang Endaryanto & Ricardo Adrian Nugraha. (2022) Safety Profile and Issues of Subcutaneous Immunotherapy in the Treatment of Children with Allergic Rhinitis. Cells 11:9, pages 1584.
Crossref
Crossref
Osman Ozan Yeğit, Semra Demir, Derya Ünal, Müge Olgaç, Kadriye Terzioğlu, Deniz Eyice Karabacak, Can Tüzer, Vehbi Ayhan, Bahattin Çolakoğlu, Suna Büyüköztürk & Aslı Gelincik. (2021) Adherence to subcutaneous immunotherapy with aeroallergens in real‐life practice during the COVID‐19 pandemic. Allergy 77:1, pages 197-206.
Crossref
Crossref
Giovanni Paoletti, Danilo Di Bona, Derek K. Chu, Davide Firinu, Enrico Heffler, Ioana Agache, Marek Jutel, Ludger Klimek, Oliver Pfaar, Ralph Mösges, Audrey DunnGalvin, Jon Genuneit, Hans Jürgen Hoffmann & Giorgio Walter Canonica. (2021) Allergen immunotherapy: The growing role of observational and randomized trial “Real‐World Evidence”. Allergy 76:9, pages 2663-2672.
Crossref
Crossref
Juan Liu, Xian Feng, Huan Wang & Hongmeng Yu. (2021) Compliance with subcutaneous immunotherapy and factors affecting compliance among patients with allergic rhinitis. American Journal of Otolaryngology 42:5, pages 103125.
Crossref
Crossref
Bernd Brüggenjürgen, Ludger Klimek & Thomas Reinhold. (2021) Real world effectiveness and cost consequences of grass pollen SCIT compared with SLIT and symptomatic treatment. Allergo Journal International 30:6, pages 198-206.
Crossref
Crossref
C. Vogelberg, B. Brüggenjürgen, H. Richter & M. Jutel. (2020) House dust mite immunotherapy in Germany: real-world adherence to a subcutaneous allergoid and a sublingual tablet. Allergo Journal International 30:5, pages 183-191.
Crossref
Crossref
Nanki Hura, Sophia SongRebecca J. KamilGerdline PierreSandra Y. Lin. (2020) Predictors of Completion of Sublingual Immunotherapy. The Laryngoscope 131:7.
Crossref
Crossref
Naoya Noguchi, Nobuo Ohta, Atsushi Yuta, Yukiko Ogawa, Yusuke Kusano, Fumi Shoji, Shiori Kitaya, Naohiro Suzuki, Chikashi Kusakari, Kunitsugu Tabata, Eikan Kaku, Naohiro Okitsu, Jun Hasegawa, Yoshihiro Shibahara, Seiichiro Nakabayashi, Naoki Inamura, Yoshiyuki Ohi, Yoshitaka Takanashi, Jun Suzuki, Mitsuru Sugawara, Kazuhiro Nomura, Yukio Katori & Yoshitaka Okamoto. (2021) Practical Study of Immunotherapy in Patients with Japanese Cedar Pollinosis Using a Questionnaire. Comparison between Sublingual Immunotherapy and Subcutaneous Immunotherapy in the Third Seasonスギ舌下免疫療法3シーズン目の効果皮下免疫療法との比較. Nippon Jibiinkoka Gakkai Kaiho 124:5, pages 748-755.
Crossref
Crossref
Matthew R. Norris, Michelle Khaimov & Leonard Bielory. (2020) Use of allergen immunotherapy for treatment of allergic conjunctivitis. Current Opinion in Allergy & Clinical Immunology 20:6, pages 609-615.
Crossref
Crossref
Danilo Di Bona, Massimo Bilancia, Marcello Albanesi, Maria Filomena Caiaffa & Luigi Macchia. (2020) Cost‐effectiveness of grass pollen allergen immunotherapy in adults. Allergy 75:9, pages 2319-2329.
Crossref
Crossref
Yusuke Kusano, Nobuo Ohta, Atsushi Yuta, Yukiko Ogawa, Fumi Shoji, Toshiichi Awataguchi, Naohiro Suzuki, Toshihiko Chiba, Shiketsu Chin, Chikashi Kusakari, Kousei Takeda, Junichi Kanbayashi, Nobuyuki Shiga, Yusuke Otake, Yusuke Suzuki, Yoshihiro Shibahara, Seiichiro Nakabayashi, Naoki Inamura, Hiroshi Osafune, Kota Wada, Seiji Kakehata, Yukio Katori & Yoshitaka Okamoto. (2020) The Survey in Clinical Practice of Sublingual Immunotherapy in Patients with Japanese Cedar Pollinosis using Self-written Questionnaire from First Season to Fourth Seasonスギ花粉症に対する舌下免疫療法の1～4シーズン目のアンケート調査. Nippon Jibiinkoka Gakkai Kaiho 123:6, pages 469-475.
Crossref
Crossref
Massimo Bilancia, Giuseppe Pasculli & Danilo Di Bona. (2020) A non-stationary Markov model for economic evaluation of grass pollen allergoid immunotherapy. PLOS ONE 15:5, pages e0232753.
Crossref
Crossref
Cristiano Caruso, Barbara Bramé, Diego Bagnasco, Alessia Cocconcelli, Valeria Ortolani, Valerio Pravettoni, Sergio Scarpa, Giuliana Zisa, Giovanni Passalacqua & Stefania Colantuono. (2020) Adherence to Allergen Subcutaneous Immunotherapy is Increased by a Shortened Build-Up Phase: A Retrospective Study. BioMed Research International 2020, pages 1-4.
Crossref
Crossref
Danilo Di Bona, Stefania Magistà, Lucia Masciopinto, Antonella Lovecchio, Roberto Loiodice, Massimo Bilancia, Marcello Albanesi, Maria Filomena Caiaffa, Eustachio Nettis, Luigi Macchia, Giuseppe Bariletto, Annamaria Carbonara, Vito Cataldo, Elisabetta Damiani, Elisabetta Di Leo, Irene Fiorino, Georgios Kourtis, Valentina Laudadio, Filomena Loconte, Anita Lotti, Enza Mastromarco, Saverio Nenna, Andrea Nico, Maria Pietrafesa, Anna Simona Rucco & Silvana Strada. (2020) Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective study. Respiratory Medicine 161, pages 105843.
Crossref
Crossref
Takahiro Imanaka, Izumi Sato, Yohei Kawasaki, Yuji Kanazawa & Koji Kawakami. (2019) An analysis of factors associated with compliance and dropout of sublingual immunotherapy on Japanese cedar pollinosis patients. International Forum of Allergy & Rhinology 9:6, pages 615-623.
Crossref
Crossref
Stefan Zielen, Kirsten Plückhahn, Yasemin Akboga, Juliane Rieker-Schwienbacher, Uta Thieme & Martin Rosewich. (2019) Fast up-dosing with a birch allergoid is safe and well tolerated in allergic rhinitis patients with or without asthma. Immunotherapy 11:3, pages 177-187.
Crossref
Crossref
Gülpembe Bozkurt, Hassan Ahmed Elhassan, Esra Sözen, Pınar Soytaş, Zeynep Nur Erol, Melih Güven Güvenç & Berna Uslu Coşkun. (2018) Assessment of taste functions in allergic rhinitis patients undergoing allergen-specific immunotherapy. European Archives of Oto-Rhino-Laryngology 276:2, pages 439-445.
Crossref
Crossref
Nobuo Ohta, Atsushi Yuta, Yukiko Ogawa, Fumi Shoji, Toshiichi Awataguchi, Naohiro Suzuki, Toshihiko Chiba, Chin Shiketsu, Chikashi Kusakari, Kousei Takeda, Junichi Kanbayashi, Nobuyuki Shiga, Yusuke Otake, Yusuke Suzuki, Yoshihiro Shibahara, Seiichiro Nakabayashi, Naoki Inamura, Hiroshi Osafune, Kota Wada, Seiji Kakehata, Yukio Katori & Yoshitaka Okamoto. (2019) Practical Study of Sublingual Immunotherapy in Patients with Japanese Cedar Pollinosis Using a Questionnaire Comparison Among the First Season, Second Season and Third Seasonスギ舌下免疫療法に関するアンケート調査. Nippon Jibiinkoka Gakkai Kaiho 122:1, pages 35-44.
Crossref
Crossref
Natalija Novak, Timo Buhl & Oliver Pfaar. (2018) Adherence During Early Allergen Immunotherapy and Strategies to Motivate and Support Patients. European Medical Journal, pages 21-29.
Crossref
Crossref
M. Rosewich. (2018) Allergenspezifische Immuntherapie bei Asthma bronchialeAllergen-specific immunotherapy for bronchial asthma. Der Pneumologe 15:3, pages 196-201.
Crossref
Crossref
G. Roberts, O. Pfaar, C. A. Akdis, I. J. Ansotegui, S. R. Durham, R. Gerth van Wijk, S. Halken, D. Larenas-Linnemann, R. Pawankar, C. Pitsios, A. Sheikh, M. Worm, S. Arasi, M. A. Calderon, C. Cingi, S. Dhami, J. L. Fauquert, E. Hamelmann, P. Hellings, L. Jacobsen, E. F. Knol, S. Y. Lin, P. Maggina, R. Mösges, J. N. G. Oude Elberink, G. B. Pajno, E. A. Pastorello, M. Penagos, G. Rotiroti, C. B. Schmidt-Weber, F. Timmermans, O. Tsilochristou, E.-M. Varga, J. N. Wilkinson, A. Williams, L. Zhang, I. Agache, E. Angier, M. Fernandez-Rivas, M. Jutel, S. Lau, R. van Ree, D. Ryan, G. J. Sturm & A. Muraro. (2018) EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy 73:4, pages 765-798.
Crossref
Crossref
Hampus Kiotseridis, Peter Arvidsson, Vibeke Backer, Vagn Braendholt & Alf Tunsäter. (2018) Adherence and quality of life in adults and children during 3-years of SLIT treatment with Grazax—a real life study. npj Primary Care Respiratory Medicine 28:1.
Crossref
Crossref
Keiko Onishi, Kayoko Kawashima, Akiyuki Yamato & Toshimichi Yasui. (2018) Investigation of sublingual immunotherapy for patients with cedar pollinosis当科におけるスギ花粉症に対する舌下免疫療法患者の検討. Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology) 57:4, pages 572-580.
Crossref
Crossref
Kuan-Wei Chen, Laura Marusciac, Paul Tudor Tamas, Rudolf Valenta & Carmen Panaitescu. (2018) Ragweed Pollen Allergy: Burden, Characteristics, and Management of an Imported Allergen Source in Europe. International Archives of Allergy and Immunology 176:3-4, pages 163-180.
Crossref
Crossref
M.-L. Lemberg, M.-J. Joisten & R. Mösges. (2017) Adhärenz in der spezifischen ImmuntherapieAdherence in specific immunotherapy. Der Hautarzt 68:4, pages 282-286.
Crossref
Crossref
Thomas Reinhold & Bernd Brüggenjürgen. (2016) Cost-effectiveness of grass pollen SCIT compared with SLIT and symptomatic treatment. Allergo Journal International 26:1, pages 7-15.
Crossref
Crossref
Thomas Reinhold & Bernd Brüggenjürgen. (2017) Kosteneffektivität einer subkutanen Gräser-Pollen-Immuntherapie im Vergleich zu sublingualen und symptomatischen Therapieansätzen. Allergo Journal 26:1, pages 26-35.
Crossref
Crossref
Nobuo Ohta, Atsushi Yuta, Yukiko Ogawa, Fumi Shoji, Toshiichi Awataguchi, Naohiro Suzuki, Toshihiko Chiba, Shiketsu Chin, Kousei Takeda, Junichi Kanbayashi, Nobuyuki Shiga, Yusuke Otake, Yusuke Suzuki, Yoshihiro Shibahara, Seiichiro Nakabayashi, Naoki Inamura, Seiji Kakehata & Yukio Katori. (2017) Practical Study of Sublingual Immunotherapy for Patients with Japanese Cedar Pollinosis Using a Questionnaire:Comparison between the First Season and Second Season. Nippon Jibiinkoka Gakkai Kaiho 120:7, pages 914-922.
Crossref
Crossref
Efren Rael. (2016) Allergen Immunotherapy. Primary Care: Clinics in Office Practice 43:3, pages 487-494.
Crossref
Crossref
A. M. Chaker, B. Al-Kadah, U. Luther, U. Neumann & M. Wagenmann. (2016) An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial. Clinical and Translational Allergy 6:1.
Crossref
Crossref
Carlo Lombardi. (2015) What is the factor that improves adherence to allergen-specific immunotherapy? A secretary!. Annals of Allergy, Asthma & Immunology 114:6, pages 530-531.
Crossref
Crossref
L. Réfabert. (2015) Immunothérapies spécifiques : quelles voies d’administration pour quelles pathologies ?. Revue Française d'Allergologie 55:3, pages 202-203.
Crossref
Crossref
Piotr Łacwik, Damian Tworek, Małgorzata Bocheńska-Marciniak & Piotr Kuna. (2015) Długofalowa skuteczność – immunoterapia alergenowa przedsezonowa czy całoroczna?. Alergologia Polska - Polish Journal of Allergology 2:2, pages 65-69.
Crossref
Crossref